TotalMarketCap

BioAge Labs

BIOANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$254.269 M

$5.54 -6.89%

Close of 6 Nov 2026

As of 6 Nov 2026, BioAge Labs (BIOA) has a market capitalization of $254.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$8.99M

#3155 by revenue

Earnings

-$80.6M

Loss-making

Shares outstanding

45,958,509

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #229ARS PharmaceuticalsSPRY$263.0M
  2. #230EvommuneEVMN$262.8M
  3. #231BioAge LabsBIOA$254.3M
  4. #232Larimar TherapeuticsLRMR$244.6M
  5. #233Bicycle TherapeuticsBCYC$243.9M

What if BioAge Labs were worth as much as…

Open the what-if tool →

Gold $28.2T

$615,223.87

Per share 111,051× higher

Bitcoin $1.53T

$33,288.69

Per share 6,009× higher

Apple $5.02T

$109,283.67

Per share 19,726× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for BioAge Labs are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.